19-17555811-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_024656.4(COLGALT1):c.98G>T(p.Gly33Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000516 in 1,260,602 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_024656.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COLGALT1 | NM_024656.4 | c.98G>T | p.Gly33Val | missense_variant | 1/12 | ENST00000252599.9 | NP_078932.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COLGALT1 | ENST00000252599.9 | c.98G>T | p.Gly33Val | missense_variant | 1/12 | 1 | NM_024656.4 | ENSP00000252599.3 |
Frequencies
GnomAD3 genomes AF: 0.00106 AC: 161AN: 151468Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00135 AC: 15AN: 11118Hom.: 2 AF XY: 0.00124 AC XY: 9AN XY: 7274
GnomAD4 exome AF: 0.000442 AC: 490AN: 1109026Hom.: 4 Cov.: 29 AF XY: 0.000419 AC XY: 222AN XY: 530364
GnomAD4 genome AF: 0.00106 AC: 161AN: 151576Hom.: 0 Cov.: 31 AF XY: 0.00143 AC XY: 106AN XY: 74082
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at